Continue to site >
Trending ETFs

Name

As of

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

-

$207 M

-

2.21%

Vitals

YTD Return

N/A

1 yr return

8.6%

3 Yr Avg Return

22.2%

5 Yr Avg Return

18.5%

Net Assets

$207 M

Holdings in Top 10

31.5%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 2.21%

SALES FEES

Front Load N/A

Deferred Load 5.00%

TRADING FEES

Turnover 76.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$1,000

IRA

$1,000


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

-

$207 M

-

2.21%

RBGHX - Profile

Distributions

  • YTD Total Return N/A
  • 3 Yr Annualized Total Return 21.5%
  • 5 Yr Annualized Total Return 18.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.48%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    AllianzGI Health Sciences Fund
  • Fund Family Name
    Allianz Funds
  • Inception Date
    Feb 05, 2002
  • Shares Outstanding
    N/A
  • Share Class
    B
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    John R. Schroer

Fund Description


RBGHX - Performance

Return Ranking - Trailing

Period RBGHX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A 2.0% 37.7% N/A
1 Yr 8.6% -25.0% 10.1% N/A
3 Yr 22.2%* -17.4% 21.9% N/A
5 Yr 18.5%* -11.0% 18.6% N/A
10 Yr 9.8%* -1.9% 15.7% N/A

* Annualized

Return Ranking - Calendar

Period RBGHX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -25.3% 7.7% N/A
2022 N/A -10.8% 43.9% N/A
2021 N/A -29.8% 2.6% N/A
2020 N/A -20.4% 13.8% N/A
2019 N/A -5.8% 31.5% N/A

Total Return Ranking - Trailing

Period RBGHX Return Category Return Low Category Return High Rank in Category (%)
YTD N/A 2.0% 37.7% N/A
1 Yr 3.9% -25.0% 13.9% N/A
3 Yr 21.5%* -17.4% 25.0% N/A
5 Yr 18.3%* -11.0% 20.7% N/A
10 Yr 9.8%* -1.9% 18.9% N/A

* Annualized

Total Return Ranking - Calendar

Period RBGHX Return Category Return Low Category Return High Rank in Category (%)
2023 N/A -25.3% 12.3% N/A
2022 N/A -10.8% 45.8% N/A
2021 N/A -24.2% 8.7% N/A
2020 N/A -16.6% 15.2% N/A
2019 N/A -5.8% 36.7% N/A

RBGHX - Holdings

Concentration Analysis

RBGHX Category Low Category High RBGHX % Rank
Net Assets 207 M 13.8 M 44.7 B N/A
Number of Holdings 78 30 398 N/A
Net Assets in Top 10 64.1 M 6.7 M 18.8 B N/A
Weighting of Top 10 31.47% 25.1% 75.2% N/A

Top 10 Holdings

  1. UnitedHealth Group Inc 4.21%
  2. Celgene Corp 3.74%
  3. AbbVie Inc 3.29%
  4. Eagle Pharmaceuticals Inc 3.09%
  5. Alexion Pharmaceuticals Inc 3.08%
  6. Regeneron Pharmaceuticals Inc 3.02%
  7. Bristol-Myers Squibb Company 2.96%
  8. Mylan NV 2.75%
  9. Vertex Pharmaceuticals Inc 2.70%
  10. Shire PLC 2.65%

Asset Allocation

Weighting Return Low Return High RBGHX % Rank
Stocks
96.10% 91.85% 103.82% N/A
Cash
3.90% 0.00% 5.40% N/A
Preferred Stocks
0.00% 0.00% 2.32% N/A
Other
0.00% -3.83% 2.75% N/A
Convertible Bonds
0.00% 0.00% 0.12% N/A
Bonds
0.00% 0.00% 0.94% N/A

Stock Sector Breakdown

Weighting Return Low Return High RBGHX % Rank
Healthcare
93.95% 13.80% 99.42% N/A
Technology
1.58% 0.00% 61.10% N/A
Consumer Defense
0.55% 0.00% 0.69% N/A
Utilities
0.00% 0.00% 0.00% N/A
Real Estate
0.00% 0.00% 1.36% N/A
Industrials
0.00% 0.00% 10.61% N/A
Financial Services
0.00% 0.00% 5.80% N/A
Energy
0.00% 0.00% 0.09% N/A
Communication Services
0.00% 0.00% 0.00% N/A
Consumer Cyclical
0.00% 0.00% 7.87% N/A
Basic Materials
0.00% 0.00% 1.91% N/A

Stock Geographic Breakdown

Weighting Return Low Return High RBGHX % Rank
US
84.30% 60.46% 99.31% N/A
Non US
11.80% 0.00% 39.02% N/A

RBGHX - Expenses

Operational Fees

RBGHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 2.21% 0.10% 2.98% N/A
Management Fee 1.20% 0.09% 1.25% N/A
12b-1 Fee 1.00% 0.00% 1.00% N/A
Administrative Fee 0.40% 0.01% 0.40% N/A

Sales Fees

RBGHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load 5.00% 1.00% 5.00% N/A

Trading Fees

RBGHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.75% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

RBGHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 76.00% 0.00% 341.00% N/A

RBGHX - Distributions

Dividend Yield Analysis

RBGHX Category Low Category High RBGHX % Rank
Dividend Yield 0.00% 0.00% 0.01% N/A

Dividend Distribution Analysis

RBGHX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Semi-Annually Annually

Net Income Ratio Analysis

RBGHX Category Low Category High RBGHX % Rank
Net Income Ratio -1.48% -2.15% 1.48% N/A

Capital Gain Distribution Analysis

RBGHX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Distributions History

View More +

RBGHX - Fund Manager Analysis

Managers

John R. Schroer


Start Date

Tenure

Tenure Rank

Jan 13, 2014

1.88

1.9%

Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. Mr. Schroer has more than 20 years of investment-industry experience. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. an M.B.A. in finance from the University of Wisconsin.

Michael Dauchot


Start Date

Tenure

Tenure Rank

Mar 01, 2005

10.76

10.8%

Dr. Dauchot, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 1999. He is part of the Health Care team, focusing on medical technology and emerging pharmaceuticals. Dr. Dauchot has 17 years of investment-industry experience. He previously worked at Pequot Capital Management and BancBoston Robertson Stephens. Dr. Dauchot has a degree in chemistry from Case Western Reserve University, an M.B.A. from the Kellogg School of Management at Northwestern University and an M.D. from the University of Cincinnati College of Medicine.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 21.8 10.26 19.18